West Virginia University Logo

Disease Site: Melanoma and Other Skin Cancers

8 protocol(s) meet the specified criteria

  • 16-009496Oncologic Outcomes Following Minimally Invasive Inguinal Lymphadenectomy for Melanoma
  • 2125-MEL-301A Randomized Phase 3 Comparison of IMO-2125 with Ipilimumab versus Ipilimumab Alone in Subjects with Anti-PD-1 Refractory Melanoma
  • CMP-001-001A Multicenter, Open-Label, Phase Ib Clinical Study of CMP-001 in Combination with Pembrolizumab in Subjects with Advanced Melanoma
  • DV3-MEL-01A Phase 1b/2, Open-label, Multicenter, Dose-escalation and Expansion Trial of Intratumoral SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  • EA6134DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) Trial
  • EAY131Molecular Analysis for Therapy Choice (MATCH)
  • INCMGA-0012-201A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma
  • LOXO-TRK-15002A Phase II Basket Study of Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors